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Abstract
Background Tumour cells are characterized by aerobic gly-
colysis, which provides biomass for tumour proliferation
and leads to extracellular acidification through efflux of
lactate via monocarboxylate transporters (MCTs). Deficient
and spasm-prone tumour vasculature causes variable hyp-
oxia, which favours tumour cell survival and metastases.
Brain metastases frequently occur in patients with advanced
breast cancer.Effective treatment strategies are therefore
needed against brain metastasis from breast carcinoma.
Material and methods In order to identify differences in the
capacity for lactate exchange, human T-47D breast cancer cells
and human glioblastoma T98G cells were grown under 4 % or
20 % oxygen conditions and examined for MCT1, MCT2 and
MCT4 expression on plasma membranes by quantitative post
embedding immunogold electron microscopy. Whereas previ-
ous studies on MCT expression in tumours have recorded
mRNA and protein levels in cell extracts, we examined con-
centrations of the proteins in the microvillous plasma mem-
brane protrusions specialized for transmembrane transport.
Results In normoxia, both tumour cell types highly expressed
the low affinity transporter MCT4, which is thought to mainly
mediate monocarboxylate efflux, while for high affinity trans-
port the breast tumour cells preferentially expressed MCT1
and the brain tumour cells resembled brain neurons in express-
ing MCT2, rather than MCT1. The expressions of MCT1 and
MCT4 were upregulated in hypoxic conditions in both breast
and brain tumour cells. The expression of MCT2 also in-
creased in hypoxic breast cancer cells, but decreased in hyp-
oxic brain tumour cells. Quantitative immunoblots showed
similar hypoxia induced changes in the protein levels.
Conclusion The differential expression and regulation of
MCTs in the surface membranes of hypoxic and normoxic
tumour cells of different types provide a foundation for
innovation in tumour therapy through the selective targeting
of MCTs. Selective inhibition of various MCTs could be an
efficient way to quench an important energy source in both
original breast tumour and metastatic cancer tissue in the
brain.
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1 Introduction
Brain metastases are frequent in patients with advanced
breast cancer, and effective strategies are crucial for treat-
ment of brain metastases, particularly in this disease [1].
Characteristic of proliferating cancer cells is the low number
of mitochondria in the cytoplasm and the high rate of
cytosolic glycolysis, even in the presence of adequate oxy-
gen. This so-called Warburg effect allows glucose moieties
to be diverted into the synthesis of macromolecules needed
for tumour cells proliferation [2–5]. Increased glycolytic
rate leads to the accumulation of lactate and pyruvate in
tumour cells, and elevated lactate levels correlate with a
tendency to metastasize and a poor prognosis [6]. The levels
of lactate and pyruvate in the cytoplasm need to be restrict-
ed, and are dependent on the regulation and expression of
monocarboxylate transporters (MCTs) on the membranes of
tumour cells [7, 8]. As a tumour grows, the distance to the
blood vessels and thereby blood flow affect the local oxygen
partial pressure and glucose concentration available to tu-
mour cells. Sonveaux and collaborators have suggested that
tumours contain oxygenated and hypoxic regions that inter-
act through the consumption and production of lactate and
that MCT1 inhibition have clinical anti-tumour potential [9].
In addition to MCT1, MCT4 and MCT2 also have the
function of lactate shuttling [10]. We therefore hypothesize
that the expression of MCTs may be different between
hypoxic and normoxic tumour cells. Altered oxygen con-
ditions in tumours can cause different mechanisms of me-
tabolism. These metabolic modifications may be reflected
by changes in MCT expression, and if sufficiently under-
stood, could provide new targets for therapy. There have
been no previous studies that have investigated the expres-
sion of different MCTs on the plasma membranes of hyp-
oxic tumour cells compared with the expression in normoxic
tumour cells. The aim of the present study was to determine
whether cycling hypoxia (4 % O2 in the gas phase) leads to
significant changes in the protein levels of different MCTs
(MCT1, MCT2 and MCT4) on the plasma membranes of
tumour cells. The protein densities were measured by quan-
titative post-embedding immunogold electron microscopy
in two human cell lines, which were divided for a prevalent
brain tumour (glioblastoma T98G) and a carcinoma (breast
cancer, T-47D), respectively.
2 Materials and methods
2.1 Cell culture
Human T-47D breast cancer cells and human glioblastoma
T98G cells (purchased from ATCC, LGC Standards AB,
SE-501 17 Boras, Sweden) were grown as monolayer
cultures in RPMI (Roswell Park Memorial Institute) 1640
medium (JRH Biosciences, Lenexa, KS, USA), supple-
mented with 10 % fetal calf serum (Gibco, Paisley, UK),
2 mM L-glutamine (SIGMA, St Louis, MO, USA), 200
units l−1 insulin (SIGMA), and 1 % penicillin/streptomycin
(Gibco) at 37 °C in air containing 5 % CO2. The cells were
cultured with two weekly reseedings, either in a normal
incubator with about 20 % oxygen (ambient air with 5 %
CO2), or in an IN VIVO2 400 glove box hypoxia worksta-
tion (Ruskinn, UK) operated to contain 4 % O2 and 5 %
CO2 in the gas phase. The pericellular oxygen concentration
was measured using a Unisense Profix 3.0 programme (Uni-
sense A/S, Aarhus, Denmark) for auto kinetic micro-sensor
measurements, a motor controller and a motorized micro-
manipulator handling an OX10 Unisense micro-sensor
(Clark-type) with a diameter of 25 μm, which was linked
to a pico-ammeter as previously described [11].
2.2 pH, lactate and glucose measurements
100 000 T98G and 500 000 T-47D cells were seeded and
placed in an incubator or in the hypoxia glove box with 4 %
O2. The pH was measured using a pH-meter from Sentron
(Roden, the Netherlands). Lactate was measured on super-
natant samples with a monitoring system (Powerlact, Med-
TRONIK, Germany) with strips (Senslab, Germany) every
day for 5 days. Glucose was measured on a monitoring
system with strips (Anscensia Contour, Bayer Health Care,
Germany).
2.3 Preparation of cells for Western blotting
and post-embedding immunogold electronmicroscopic analysis
The Western blotting for antibody testing was carried out on
T98G and T-47D cells cultured in air containing 20 %
oxygen. For post-embedding immunogold electron micros-
copy we used T98G and T-47D cells cultured in air contain-
ing either 4 % or 20 % oxygen. Cells were harvested by
centrifugation at 15000 rpm for 10 min and stored in form-
aldehyde (4 %, freshly depolymerized from paraformalde-
hyde) and glutaraldehyde 0.1 %, freshly added in 0.1 M
sodium phosphate buffer pH 7.4 at 4 °C until further
processed.
2.4 Primary antibodies
MCT1 M: Chicken anti MCT1 antibody was obtained from
Millipore (USA). MCT2 G: Goat anti MCT2 antibody was
obtained from GenWay Biotech (USA). MCT4 A: Rabbit
anti MCT4 (SLC16A3) was obtained from Abcam (UK).
MCT2 H and MCT4 H: Rabbit anti MCT2 and rabbit anti
MCT4 were obtained from Professor A. P. Halestrap, Uni-
versity of Bristol, UK.
218 C. Cheng et al.
2.5 Western blot analysis
Cells were harvested by trypsinization, rinsed twice with
PBS and scraped into a RIPA buffer (Thermo Scientific
Pierce, Germany) with a protease inhibitor (0.1 μM Aproti-
nin, 1.0 mM PMSF, 1 μM Leupeptin, 1 μM Pepstatin).
Insoluble materials were removed by centrifugation and
the protein concentration was measured. After boiling at
100 °C for 5 min in a SDS-loading buffer, equal amounts
of protein per sample were separated by SDS-PAGE and
transferred onto polyvinylidene difluoride transfer mem-
branes (BIO-RAD, USA). The membranes were blocked
Fig. 1 Electron micrographs of
membrane area. a Illustration of
the tumour cells (grey), gold
particles (yellow) and
membrane area (green). b Low
magnification transmission
electron micrograph from T-
47D cells. c High magnification
from (b) green square, cell
membrane region. d Low mag-
nification from T98G cells. e
High magnification from (d)
green square. The morphology
is characteristic of tumour cells
with nuclear atypia. The area
between plasma membranes of
two cells is covered with mi-
crovillous processes extended
from the cell surface. Blue area,
cell body; Blue lines, cell
membranes; Red lines, nuclear
membranes; Green square,
membrane area; Scale bars,
5 μm in B and D, 500 nm in C
and E; insets, 50 nm in C and E
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with 5 % non-fat dry milk in PBST for 2 h at room temper-
ature and reacted with the primary antibodies (diluted
0.5 μg/ml in PBST/5 % milk) at 4 °C overnight, followed
by incubation with secondary HRP-conjugated antibodies.
Immuno-complexes were visualized by enhanced chemilu-
minescence (GE Healthcare UK). The protein bands were
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quantitatively analyzed using Nikon image analysis soft-
ware (NIS-Elements BR 3.1). All data concerning the level
of specific proteins were normalized to the level of GAPDH.
Western blotting experiments were repeated at least three
times.
2.6 Post-embedding immunogold electron microscopy
The procedure for post-embedding immunogold electron
microscopy was adapted from Bergersen and colleagues
[12]. The ultrathin sections were incubated overnight with
primary antibodies against MCT1, MCT2 or MCT4 diluted
in TBST containing 2 % HAS. The concentration of all
MCTs were 5 μg/ml. Bound antibodies were visualized by
incubating for 2 h with secondary (rabbit anti-chicken, goat
anti-rabbit or rabbit anti-goat) immunoglobulin conjugated
with 10 nm diameter colloidal gold (British Biocell Interna-
tional, UK). Sections were observed using a Tecnai 12
electron microscope. Pictures were taken randomly from
the border region between two cells at primary magnifica-
tions of ×43 000.
2.7 Quantitative immunogold analysis
A quantitative analysis of electron microscopic immunogold
micrographs with clear plasma membranes were taken ran-
domly from the sample. For each antibody solution (MCT1
M, MCT2 G, MCT2 H, MCT4 A and MCT4 H) and each of
the four kinds of cells (T98G or T-47D cells grown with
either 4 % or 20 % oxygen in the gas phase), 120 (MCT1 M,
MCT2 G and MCT4 A) or 50 (MCT2 H and MCT4 H)
micrographs were analysed. For each micrograph, cell mem-
branes were marked by software ImageJ with Point density
plug-in. The area between two cells creating a border region
(Figs. 1 and 5, area between blue lines) was calculated and
gold particles situated in the region, including 25 nm on
each side of the membranes, were marked by the software
[12]. This region contains most of the plasma membranes
present in the samples, i.e. the transected plasma membrane
covering the microvillous protrusions and the intervening
areas of the tumour cell surface. The approximate density of
transporters associated with the plasma membranes was
calculated as the number of gold particles divided by the
area.
In addition, 20 micrographs from each type of cell and
antibody with a clear cytoplasmic area were taken out ran-
domly, and the density of gold particles in this area without
mitochondria was calculated, to compare them with the
density at the plasma membrane.
2.8 Statistical analysis
All quantitative data are represented as mean ± standard error
of the mean, and the statistical significance was determined




Cells cultivated under low-oxygen conditions were grown in
a hypoxia box with 4 % oxygen in the atmosphere, which is
close to the oxygen level in normal tissue (3–5 %) [13]. The
cells need at least 2 weeks to adapt to the hypoxic condi-
tions. At the time of the harvest and subsequent MCT
analysis, the T98G cells had been grown with 4 % oxygen
in the gas phase for 4 weeks and the T-47D cells for 2 weeks
with two weekly reseedings. During this time the cells
experienced cycling hypoxia as the pericellular oxygen level
started at 4 % at each reseeding and ended below 0.1 %
when the cell flasks were nearly full [14].
Figure 2 shows data from one such cycle and equivalent
data for cells grown in ambient air. The change in the
pericellular oxygen concentration as the cell number in-
creased between reseedings is shown for cells cultured with
4 % oxygen in the gas phase (Fig. 2a). The T98G cells
(median diameter 19.4 μm) are larger than the T-47D cells
(median diameter 13.8 μm), and they also have a shorter
doubling time (24±2.4 h versus 28.8±2.4 h). For that rea-
son, the T98G cells were seeded at a lower number (∼105)
than the T-47D cells (∼5 x 105), which is reflected in the
longer time needed to reach the lowest pericellular oxygen
concentration below 0.1 %.
The cells harvested for MTC analysis were grown in either
20 % or 4 % oxygen. The change in the total cellular mass in
each flask (Fig. 2c) was calculated from the median cell
diameter and cell number (Fig. 2b). The medium was changed
on day 2 in order to provide enough glucose for further
proliferation, and this influenced the measured lactate and
glucose concentrations. As a result, the glucose, lactate and
pH measurements are only shown after the medium change
Fig. 2 T-47D and T98G cells were grown either in 20 % or 4 %
oxygen. The medium was changed on day 2. a The change in peri-
cellular oxygen concentration as cell number increases between reseed-
ings in cells flasks cultured with 4 % oxygen in the gas phase. Results
from one representative experiment are shown. b T-47D cells and
T98G cells were seeded at numbers resulting in full but not confluent
flasks at day 4 for the MCT analysis. In addition measurements of
lactate, glucose and pH were done in flasks with the same number of
T98G cell as T-47D cells. c The cellular mass calculated from the cell
volume and cell numbers from panel b. Panels d–f show the data after
the medium change. d Glucose concentration (black square shows
measurement of medium). e Lactate concentration (black square shows
measurement of medium). f pH. Error bars show standard error of the
mean from two parallel flasks
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(Fig. 2d–f). The data include measurements of flasks seeded
with the same number of T98G cells as used for T-47D cells
(∼5×105) as well as the number of T98G cells used in the
MTC-analysis experiment (∼1×105). The T-47D cells (when
grown in both 4 % and 20 % oxygen) had used all available
glucose on day 4 and the densely seeded T98G cells already
exhausted the reserves about day 3. The sparsely seeded T98G
cells did not consume all glucose (Fig.2d). The lactate produc-
tion from day 2 to day 3 was higher in the flasks with the
higher number of cells before all cell flasks reached approxi-
mately the same level on day 4. There was a tendency in both
cell lines toward a larger lactate production in the hypoxic cells
compared to normoxic cells on day 3 except in the densely
seeded T98G flasks where the high level seen in all flasks on
day 4 was already reached on day 3 (Fig. 2e).
The media of both cell lines reached a very low pH on
day 4 in the flasks grown in 4 % oxygen (Fig. 2f). The
densely seeded T98G cells and the hypoxic T-47D cells
reached a low pH a day before sparsely seeded hypoxic
T98G cells. There was a tendency towards higher pH in
the cells grown in 20 % compared to 4 % oxygen except in
the densely seeded T98G cells on day 3, but this was only
statistically significant for T-47D cells on day 4 (p00.004).
3.2 Specificity of antibodies and total protein levels of each
individual MCT upon hypoxia compared with normoxia
The antibodies to MCT1 Millipore, MCT4 Abcam, MCT4
Halestrap, MCT2 GenWay and MCT2 Halestrap showed
single bands in immunoblots prepared from T98G and T-
47D tumour cells. The positions of the bands are consistent
with the reported molecular masses of the different subtypes
of MCT transporters (Fig. 3a). Total relative MCT protein
levels in cells were calculated by the ratio of MCT grey
values to those for GAPDH loading control. MCT1 and
MCT4 levels increased significantly in hypoxic T-47D and
T98G tumour cells compared with normoxic cells, whereas
MCT2 level increased in T-47D cells and decreased in T98G
cells after hypoxic cultivation (Fig. 3b, c).
3.3 MCTs distribution in normoxic or hypoxic T-47D
and T98G cells
The presence of cellular MCTs in electron micrographs was
displayed and quantified using immunogold analysis. For all
of the MCTs, the densities were several times higher in the
surface membrane regions compared to the cytoplasmic
regions (Fig. 4a–e), despite the fact that the membrane area
was diluted with extracellular space and intravillous cyto-
plasm. The MCTs were therefore highly concentrated in the
plasma membrane.
When normoxic and hypoxic cells were compared, the
membrane density of MCT1 was significantly higher in cells
grown with 4 % oxygen than in normoxic cells, both for T-
47D and T98G cells (all p<0.0001, Student’s t-test) (Fig. 4a
and 5). The membrane density of MCT4 in hypoxic T-47D
and T98G cells was significantly higher than that of normoxic
tumour cells (all p<0.0001, Student’s t-test) (Fig. 4b, c and 5).
The antibodies from Abcam and Halestrap gave similar results.
In contrast, the density of MCT2 revealed a difference
between T-47D and T98G cells. In T-47D cells, the density
of MCT2 on plasma membranes in hypoxic cells was signif-
icantly higher than that of normoxic cells (all p<0.0001,
Student’s t-test). However, in T98G cells, the density of
MCT2 on plasma membranes in cells grown with 4 % oxygen
was significantly lower than that of normoxic cells (all p<
0.0001, Student’s t-test) (Fig. 4d, e and 5). Antibodies from
GeneWay and Halestrap yielded similar results. The higher
labelling intensity of the latter was associated with a lesser
relative change between hypoxic and normoxic cells.
4 Discussion
Through our studies, we have found that hypoxia causes
changes in the densities of MCT proteins in the surface
membrane protrusions of malignant tumour cells. In the
breast cancer-derived cell line T-47D, all of the MCTs
generally expressed in mammalian cells, i.e. MCT1,
MCT2 and MCT4, showed upregulation under hypoxic
conditions. During similar conditions, the glioblastoma-
derived cell line T98G displayed MCT 1 and MCT4 upre-
gulation, whereas MCT2 was downregulated.
These results suggest that tumour cells increase removal
of lactate from glycolytic cells and increase lactate uptake
by oxidative tumour cells. The question is what are the
consequences of increased export and uptake of lactate?
Increased export of lactate to medium lowers pH of the
cellular environment and the extra-cellular matrix. This
may influence remodelling of the matrix [15]. On the
other hand, increased lactate uptake changes mitochon-
drial respiration. Increased mitochondrial respiration
generates increased reactive oxygen species (ROS), increased
oxidative damage to proteins and DNA, which generate ge-
nomic instability. Interestingly, increased ROS and mitochon-
drial dysfunction have been linked to malignancy in breast
cancer [16, 17]. Decreased mitochondrial respiration lowers
the ROS levels and generates genetic instability that is differ-
ent from that previous described [18, 19]. This resembles
induction of the Warburg effect [4] by ROS mediated inhibi-
tion of pyruvate kinase, which reduces pyruvate oxidation in
mitochondria and thereby diverts glycolytic products into
pathways promoting biosynthesis and increased ROS break-
down, both facilitating tumour growth [20].
This is the first study to demonstrate significant changes in
the concentrations of MCT proteins in the plasma membrane
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Fig. 3 Antibody specificity and MCT protein quantification. a Immuno-
blots from T98G tumour cells and T-47D cancer cells gave for all anti-
bodies single bands at a molecular weight of approximately 49–58KD for
MCT1 M (55 KD), MCT2 G (58 KD), MCT2 H (60 KD), MCT4 A (49
KD) and MCT4 H (52 KD). The results are consistent with the molecular
mass of the proteins and the descriptions from the antibody suppliers. b
The immunoreactive bands show the expression of each MCT in hypoxia
and normoxia, in T-47D and T98G tumour cells. c The level of MCT1,
MCT4 and MCT2 increased in T-47D cells after hypoxic cultivation,
whereas a significant MCT2 expression decrease was detected in hypoxic
T98G cells. Error bars show standard error of the mean. The asterisk
indicates a statistically significant difference (P<0.05) between hypoxia
and normoxia
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of tumour cells. Specifically, we show that the changes occur
in the microvillous region of the surface membrane,
specialized for the exchange of solutes with the surroundings.
Previous studies in various cell-types have recorded levels of
Fig. 4 The density of MCTs on plasma membranes and cytoplasm. The
density of MCTs on the membranes of hypoxic tumour cells and normoxic
cells were significantly higher than that on cytoplasm areas without mito-
chondria areas. a–c The MCT1 and MCT4 density on membranes of
hypoxic cells was significantly higher than that of normoxic cells in both
T-47D and T98G cells. d–e The MCT2 density of T-47D hypoxic cells was
significantly higher than that of normoxic cells. For T98G cells, it is the
reverse. Error bars show standard error of the mean. Asterisks indicate
statistically significant differences (p < 0.05) between hypoxia and normoxia
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protein in tumour tissues [21]. In the present study, we show
that the concentrations of MCTs in cytoplasmatic areas are
much lower than the areas containing plasma membranes, and
also that they are less clearly different in normoxic and hyp-
oxic specimens. Since the cytoplasmatic areas are large, the
combined amount of MCTs in such an intracellular reservoir
could be vast compared to the amounts inserted in or removed
from the membrane in response to hypoxia, thereby explain-
ing the lack of clear change observed in MCT densities in the
cytoplasm. This may also explain the previously reported lack
of hypoxia-induced changes in the expression of MCT pro-
teins, when measured in cell extracts [22].
However, our immunoblots from extracts of cultured
cells show that the hypoxia induced changes also comprise
Fig. 5 Electronic micrographs from T-47D and T98G cells with dif-
ferent MCTs. In electron micrographs, gold particles signalled immu-
noreactivity to MCT. To quantify the labelling of different transporter
subtypes, the area between two cells creating a border region was
calculated and gold particles (red arrows) situated in the region,
including 25 nm on each side of the membranes (approximately the
same distance as the lateral resolution of the immunogold method
(Bergersen et al. 2008)), were marked by ImageJ software. The density
of transporters’ immunoreactivity in the region containing microvillous
processes of the surface membrane was calculated as the number of
gold particles divided by the area. Red arrows, gold particles; Scale
bars, 500 nm; insets, 100 nm
Monocarboxylate Transporters in Hypoxic Tumour cells 225
the total cellular levels of the MCTs, and therefore are not
solely due to redistribution between membrane and intracel-
lular stores. The low-affinity transporter MCT4 (Km about
35 mM) is generally associated with the export of mono-
carboxylates from cells, whereas the high-affinity transport-
ers MCT1 and MCT2 are thought to primarily mediate the
uptake from extracellular fluid. The observed hypoxia-
induced upregulation of MCT4 in both cell lines is therefore
in agreement with the demonstrated increased export of
lactate to the medium. The upregulation of MCT1 in both
cell lines, and of MCT2 in T-47D cells, may contribute to
lactate efflux, but could also be viewed from the perspective
of the proposed symbiotic relationship that exists within
solid tumours between separate regions with different oxy-
gen supply: normoxic cells close to blood vessels import
and oxidize lactate released from hypoxic cells further away
from vessels, thereby saving glucose the latter can use [9].
In addition, tumours typically undergo cycles of varying
hypoxia [23], requiring cells to be prepared for episodes of
net release of lactate alternating with episodes of net uptake
to utilize the available oxygen for energy production.
The restricted oxygenation conditions in tumours bear
some resemblance to those found in adipose tissue, particu-
larly in the obese. Interestingly, hypoxia-induced changes
similar to the ones observed by us in the glioblastoma-
derived cells T98G were reported in adipocytes, i.e. the
upregulation of MCT1 and MCT4 and the downregulation
of MCT2 [15]. Adipocytes have recently been recognized to
be akin to neuroendocrine cells, e.g. expressing the molec-
ular machinery for neurotransmitter production [24]. As
T98G cells are derived from glioblastoma tumours that
originate in the nervous system and contain neural stem
cells [25], they may be expected to behave more similarly
to adipocytes than to the breast cancer-derived T-47D cells.
What can be the rationale for the downregulation of MCT2
in the T98G cells? A possibility is that the cells need to protect
themselves from losing a critical substance or from the uptake
of an adverse one. In this context, it is interesting that MCT2
has a higher affinity for pyruvate than the other MCTs, both in
absolute terms and relative to lactate [26, 27]. The down-
regulation of MCT2 would therefore limit the loss of pyruvate
to the medium, saving it for later conversion to lactate regen-
erating NAD+ from NADH or to metabolites supporting cell
proliferation and growth. One additional possibility may be
the necessity of regulating pH, which is central to the biology
of tumours, notably for the ability to metastasize [28]. The
high affinity of MCT2 for substrates may offer advantages
over MCT1 and MCT4 in this respect.
It can be debated whether our choice of adjusting the cell
numbers to result in a similar cellular mass was better than
using similar cell numbers. On the one hand one can see that
glucose is exhausted after 3 days in the densely seeded
T98G culture, but not in the T-47D culture. This does not
happen in the sparsely seeded T98G culture, thus to some
extent supporting our choice. On the other hand the time
course of pH in the densely seeded T98G cultures seems to
be more in line with that of T-47D cultures than that of
sparsely seeded T98G cultures. However, the cells were
harvested after several cycles of hypoxia/reoxygenation
and the treatment certainly resulted in different levels of
the MCT-proteins in both cell lines compared to cell grown
in ambient air. Interestingly, even if the lactate levels were
the same in all cell flasks, the pH levels seemed to be lower
in the hypoxic cell flasks (only statistically significant for T-
47D cells). Plotting lactate as a function of pH (not shown)
shows that the pH levels appear to continue to drop after a
stabilization of lactate levels regardless of oxygen level.
Thus, as the cells grow confluent, there must be other
mechanisms responsible for acidification.
5 Conclusions
The low affinity transporter MCT4, which is thought to
mainly mediate the cellular export of monocarboxylates,
was highly expressed by both the breast cancer-derived T-
47D cells and the glioblastoma-derived T98G cells, and was
upregulated in hypoxia in both cell types. The ubiquitously
expressed high affinity transporter MCT1 was high in the
breast cancer cells though low in glioblastoma cells in
normoxia, but nonetheless was upregulated by hypoxia in
both cell types. In contrast, the glioblastoma cells resembled
neurons in expressing the high affinity transporter MCT2,
rather than MCT1. Intriguingly, these cell down regulated
MCT2 in hypoxia. Since MCT2 has a particularly high
affinity for pyruvate, the observed down regulation may
serve to prevent the leakage of pyruvate, conserving it for
anaerobic energy production through conversion to lactate.
The differential expression and regulation of MCTs in hyp-
oxic and normoxic tumour cells opens possibilities for the
innovation of tumour therapy through the selective targeting
of monocarboxylate metabolism.
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